FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LENVATINIB
异名/同义词4-(3-CHLORO-4-((CYCLOPROPYLAMINOCARBONYL)AMINO)PHENOXY)-7-METHOXY-6-QUINOLINECARBOXAMIDE
4-(3-CHLORO-4-((CYCLOPROPYLCARBAMOYL)AMINO)PHENOXY)-7-METHOXYQUINOLINE-6-CARBOXAMIDE
6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)- 7-METHOXY-
6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)-7-METHOXY-
ER-203492-00
LENVATINIB
LENVATINIB [INN]
LENVATINIB [MI]
LENVATINIB [USAN]
LENVATINIB [WHO-DD]
N-(4-((6-CARBAMOYL-7-METHOXYQUINOLIN-4-YL)OXY)-2-CHLOROPHENYL)-N'-CYCLOPROPYLUREA
E7080
E-7080
CAS登记号417716-92-8
物质唯一标识(Unique Ingredient Identifier)EE083865G2
分子式C21H19ClN4O4
国际化合物标识(International Chemical Identifier,InChI)WOSKHXYHFSIKNG-UHFFFAOYSA-N
SMILESc1(cc2c(nccc2Oc3cc(c(cc3)NC(NC4CC4)=O)Cl)cc1OC)C(N)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System